Lv5
1028 积分 2025-01-11 加入
Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration
1天前
已完结
Recent Advances in Embolic Agents for Transarterial Chemoembolization of Hepatocellular Carcinoma
1个月前
已完结
Interventional therapy for hepatocellular carcinoma in the immunotherapy era: From mechanism exploration to materials innovation
1个月前
已完结
Mitigating tumor heterogeneity in lung Cancer: A dual-targeted NIR-II imaging strategy for accurate tumor localization and intraoperative navigation
1个月前
已完结
Fibroblast activation protein peptide-targeted NIR-I/II fluorescence imaging for stable and functional detection of hepatocellular carcinoma
1个月前
已完结
Cancer‐Associated Fibroblasts Promote Tumor Immunosuppression in Hepatocellular Carcinoma via the NNMT‐ANGPTL4 Axis
1个月前
已完结
JOSD1 drives hepatocellular carcinoma malignancy by modulating the ubiquitination-lactylation switch on PGAM1
1个月前
已完结
Viscosity-responsive NIR-II fluorescent probe with aggregation-induced emission features for early diagnosis of liver injury
1个月前
已完结
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
3个月前
已完结
Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab–bevacizumab
3个月前
已完结
皖公网安备34019202002308
